Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Viridian Therapeutics, Inc.\DE (VRDN) Preferred Dividend Payments (2016 - 2017)

Historic Preferred Dividend Payments for Viridian Therapeutics, Inc.\DE (VRDN) over the last 2 years, with Q1 2017 value amounting to $5000.0.

  • Viridian Therapeutics, Inc.\DE's Preferred Dividend Payments rose 14166.67% to $5000.0 in Q1 2017 from the same period last year, while for Dec 2017 it was $5000.0, marking a year-over-year decrease of 8000.0%. This contributed to the annual value of $5000.0 for FY2017, which is 8979.59% down from last year.
  • Latest data reveals that Viridian Therapeutics, Inc.\DE reported Preferred Dividend Payments of $5000.0 as of Q1 2017, which was up 14166.67% from $12000.0 recorded in Q4 2016.
  • Over the past 5 years, Viridian Therapeutics, Inc.\DE's Preferred Dividend Payments peaked at $13000.0 during Q3 2016, and registered a low of -$12000.0 during Q1 2016.